Clinical Trials
50 trials registered for Rett syndrome
An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome
NCT02562820Phase 1The Cleveland Clinic
Terminated↗
An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
NCT04988867Phase 2/3ACADIA Pharmaceuticals Inc.
Terminated↗
Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
NCT03848832Phase 3Jazz Pharmaceuticals
Terminated↗
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
NCT02790034Phase 2/3Newron Pharmaceuticals SPA
Terminated↗
Open-Label Extension Study of Trofinetide for Rett Syndrome
NCT04776746Phase 3ACADIA Pharmaceuticals Inc.
Terminated↗
Trial of Dextromethorphan in Rett Syndrome
NCT00593957Phase 2Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Terminated↗
Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome
NCT00069550Phase 3Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Unknown↗
Patients With RETT Syndrome
NCT04014985N/AAssistance Publique Hopitaux De Marseille
Unknown↗
Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin
NCT02696044Phase 2Center for Rare Neurological Diseases, Norcross, GA
Unknown↗
An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
NCT02226458Phase 2Edison Pharmaceuticals Inc
Withdrawn↗